TAK vs TEVA: stock comparison and AI forecast
Takeda Pharmaceutical Co Ltd (TAK) and Teva Pharmaceutical Industries Ltd (TEVA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
TAK Takeda Pharmaceutical Co Ltd
- Price
- $20.01 +20.0% · 6M
- Market Cap
- $62.51B
- P/E Ratio
- 6.0x
- Size
- large-cap
- AI Forecast
TEVA Teva Pharmaceutical Industries Ltd
- Market Cap
- $47.43B
- P/E Ratio
- 84.8x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- TAK is 1.3 times larger than TEVA by market capitalization ($62.51B against $47.43B).
- TAK trades at 6.0 times trailing earnings, TEVA at 84.8 times.
- TEVA turns 45.4% of its revenue into net income, against 4.9% for TAK.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | TAK | TEVA |
|---|---|---|
| Market Cap | $62.51B | $47.43B |
| P/E Ratio | 6.02x | 84.79x |
| P/B Ratio | – | 6.12x |
| EPS | $3.32 | $0.48 |
| Book Value/Share | – | $6.65 |
| Revenue/Share | $34.55 | $1.34 |
| FCF/Share | $6.79 | $1.16 |
Profitability & Margins
| Metric | TAK | TEVA |
|---|---|---|
| ROE | – | 9.1% |
| ROA | – | 1.8% |
| ROIC | – | 6.6% |
| Gross Margin | 67.4% | -428.7% |
| Operating Margin | 9.2% | 103.0% |
| Net Margin | 4.9% | 45.4% |
| EBT Margin | 5.5% | 46.4% |
| Tax Rate | 11.7% | 1.7% |
Financial Health
| Metric | TAK | TEVA |
|---|---|---|
| Current Ratio | – | 0.88x |
| Quick Ratio | – | 0.67x |
| D/E Ratio | – | 4.14x |
| Financial Leverage | – | 5.14x |
| Interest Coverage | – | 0.3x |
| Working Capital | – | -$1.89B |
Cash Flow
| Metric | TAK | TEVA |
|---|---|---|
| Operating Cash Flow | $25.43B | $1.90B |
| Free Cash Flow | $21.23B | $1.35B |
| Capital Spending | -$4.20B | -$550M |
| OCF Growth YoY | – | 36.5% |
| FCF Growth YoY | 0.0% | 51.5% |
| FCF/Sales | 19.7% | 86.6% |
| CapEx/Sales | 3.9% | 35.3% |
Operational Efficiency
| Metric | TAK | TEVA |
|---|---|---|
| Asset Turnover | – | 0.04x |
| Receivables Turnover | – | 0.5x |
| Inventory Turnover | – | 2.6x |
| Fixed Assets Turnover | – | 0.4x |
| Days Sales Outstanding | – | 819 days |
| Days Inventory | – | 143 days |
Income Statement
| Metric | TAK | TEVA |
|---|---|---|
| Total Revenue | $107.93B | $1.56B |
| Operating Income | $9.90B | $1.60B |
| Net Income | $5.25B | $707M |
| R&D Expense | $17.20B | $1.49B |
| SG&A Expense | – | $4.46B |
| Cost of Goods Sold | $35.17B | $8.23B |
Dividend & Shareholder Information
| Metric | TAK | TEVA |
|---|---|---|
| Shares Outstanding | 3124M | 1165M |
TAK vs TEVA: stock comparison and AI forecast
Which is bigger, TAK or TEVA?
TAK is 1.3 times larger than TEVA by market capitalization ($62.51B against $47.43B).
Which is cheaper on earnings, TAK or TEVA?
TAK trades at 6.0 times trailing earnings, TEVA at 84.8 times.
Which one does Intratio's AI model rank higher, TAK or TEVA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.